Clinical trial Recruiting at 1 site Phase1; Phase2 Interventional Ages 21 to 70

Psilocybin-assisted therapy to improve physician well-being and reduce burnout

Official title: Psilocybin-Assisted Therapy for Physician Well-Being and Burnout: Feasibility, Safety, Clinical Effectiveness and Biomarkers of Response [PAT-B (Psilocybin-Assisted Therapy for Physician Well-Being and Burnout)]

Run by University of California, San Diego · NCT06814522 · Data updated 2026-11-12

This project will test whether psilocybin-assisted therapy can reduce burnout and improve well-being in physicians at UC San Diego.

More Burnout trials

Quick facts

PhasePhase1; Phase2
Study typeInterventional
Ages21 Years to 70 Years
SexAll
Enrollment30 (estimated)
SponsorUniversity of California, San Diego
Academic / other
Locations1 site (San Diego, California)
StatusRecruiting
StartedJanuary 13, 2025
Main results expectedJune 2028
Study endsAugust 2028
Registry record updatedSeptember 2, 2026
Trial IDNCT06814522 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are UC San Diego faculty physicians aged 21–70 who have had burnout symptoms for more than six months, can attend all in-person visits, and do not have serious mental illness or disallowed medications.

Probably not a fit

Physicians with a history of psychotic or bipolar disorders, prior inpatient psychiatric hospitalization, active substance use disorder, or those taking psychotropic drugs that risk serotonin syndrome are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This open-label Phase 1/2 trial will enroll UCSD faculty physicians experiencing persistent burnout and deliver preparatory psychotherapy, a supervised psilocybin dosing session, and post-treatment integration sessions. Burnout symptoms will be measured using the Stanford Professional Fulfillment Index before and after treatment, and safety and feasibility outcomes will be tracked throughout. A secondary aim is to record neurophysiological changes with EEG to explore mechanisms associated with clinical response. The protocol excludes people with psychotic or bipolar disorders, recent inpatient psychiatric hospitalization, active substance use disorder, or current use of certain psychotropic medications.

Why it matters

Potential benefit: If successful, this approach could offer a rapid and durable option to reduce physician burnout and improve professional well-being.

How similar studies have gone: Small psilocybin-assisted therapy trials have shown preliminary efficacy for depression and substance use disorders, but using PAT specifically for physician burnout is novel and not yet established.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Faculty physician, aged 21-70. Volunteer faculty are not included
2. Meets criteria for physician burnout
3. Experiencing symptoms of burnout for \>6 months
4. Able to complete all required study visits
5. Not previously diagnosed with a serious mental illness (including schizophrenia, bipolar disorder, and severe depression), or substance use disorder as confirmed in clinical interview
6. Not currently taking any psychotropic medications or nonpsychotropic medication that may be associated with serotonin syndrome, such as serotonin reuptake inhibitors (SSRI or SNRI), dextromethorphan, linezolid, tramadol, meperidine

Exclusion Criteria:

1. Previous inpatient psychiatric hospitalization(s)
2. Previously diagnosed with a psychotic disorder (schizophrenia, schizoaffective disorder, or other psychotic spectrum disorder), bipolar spectrum disorder, personality disorder (borderline personality disorder, antisocial personality disorder, or other severe personality disorders), any severe psychiatric disorder.
3. Exhibiting elevated suicide risk
4. First degree family history of psychosis or bipolar disorder
5. Prior exposure to psilocybin or other psychedelic compounds in the previous 5 years
6. Currently pregnant, nursing, planning pregnancy, engaging in sexual intercourse without effective contraceptive method in last three months
7. Those who plan to donate sperm within three months following the study.
8. Known cardiovascular disease including history of stroke, myocardial infarction, uncontrolled hypertension, valvular heart disease, tachycardia, elongated QT interval, or clinically significant arrythmia.
9. History of seizure disorder
10. Use of recreational illicit drugs
11. Clinically concerning results from vital signs, ECG, physical examination, or laboratory tests during screening
12. Any other clinically significant illnesses deemed to pose risk for the participant

Where it's running

  • UC San Diego
    San Diego, California, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.